Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Experimental blood cancer drug trial halted early

NCT ID NCT03922100

First seen Mar 20, 2026 · Last updated May 24, 2026 · Updated 13 times

Summary

This study tested an experimental drug called NMS-03592088 in 63 adults with acute myeloid leukemia (AML) or chronic myelomonocytic leukemia (CMML) that had come back or not responded to standard treatments. The goal was to find a safe dose and see if the drug could shrink or control the cancer. The trial was stopped early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • ASST Grande Ospedale Metropolitano Niguarda

    Milan, MI, 20162, Italy

  • ASST Papa Giovanni XXIII

    Bergamo, BG, 24127, Italy

  • ASST Spedali Civili di Brescia

    Brescia, 25123, Italy

  • Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi

    Bologna, 40138, Italy

  • CHU Hopitaux de Bordeaux - Hôpital Haut-Lévêque

    Pessac, 33604, France

  • Centre Hospitalier Lyon-Sud

    Pierre-Bénite, 69495, France

  • Centre Hospitalier Universitaire de Nantes (CHU de Nantes) - Hotel-Dieu

    Nantes, 44000, France

  • Centre Hospitalier du Mans

    Le Mans, 72037, France

  • Fondazione Policlinico Universitario Agostino Gemelli

    Roma, 00168, Italy

  • Hospital Universitari i Politècnic La Fe

    Valencia, 46026, Spain

  • Istituto Clinico Humanitas

    Rozzano, MI, 20089, Italy

Conditions

Explore the condition pages connected to this study.